News
Press Release: Nucleus Biologics Announces Growth, Expansion to New Office
For immediate release Nucleus Biologics Announces Growth, Expansion to New Office San Diego-based cell culture products supplier announces n...
Press Release: Nucleus Biologics Announces Highest Levels of Fetal Bovine Serum Testing in Industry
For immediate release Nucleus Biologics Announces Highest Levels of Fetal Bovine Serum Testing in Industry to “Re-Define” Serum ...
Shifting Quality of FBS May Impact Your Experiments
Four Steps to Ensuring Greater Quality & Consistency in FBS and Scientific Research By Alyssa Master, Ph.D. Cell culture and in vitro m...
Fetal attraction? FBS supplier offers price guarantee for ‘cell food’ mainstay
Lot-to-lot consistency is key for fetal bovine serum (FBS) supply, says Nucleus Biologics which is offering clients stable volumes and price...
Press Release: Launch of First Premium Cell Culture Product
Company partners with supplier to provide a long-term supply of cGMP quality, consistent, characterized FBS via an exclusive Australian sour...Blog
A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum
BioProcessing Journal has published the article “A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum” by Mic...
Cool Tool – Xeno-free media supplement for Cell Therapy Manufacturing
A growing trend is the use of xeno-free media or media supplements to provide cells with the nutrients they crave, while providing regulator...FBS – It’s not all created equal – What consumers need to know
Cell Culture Dish podcast interviewing Alyssa Master, Ph.D., Senior Manager of Science and Applications, Nucleus Biologics about some of the...
Methods for Determining Authenticity of Fetal Bovine Serum
We recently encountered a customer who had purchased their fetal bovine serum (FBS) at a very low price. Anytime we hear about FBS selling ...
Nucleus Biologics’ Alyssa Master Named to San Diego Daily Transcript 40 Under 40
We have known all along that our very own Senior Manager of Science and Applications, Alyssa Master, is amazing, and now the San Diego Daily...
“Re-Defined” FBS: Bridging the Gap for Better Science
Fetal bovine serum (FBS) has been a critical mainstay in cell-based pharmaceutical research and bioproduction, providing the food for cells ...
Mitigating Your Risks: Geographical BSE Risk Assessment
By Dr. Alyssa Master There is an inherent risk in utilizing cell culture media supplements that originate in animals. However, researchers c...
The Nucleus Biologics Story
Why Fetal Bovine Serum? Nucleus Biologics was formed with the vision to improve the outcome of cell based experiments by addressing the elep...Articles
Gene Therapy
- RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
- Everything You Need To Know About Gene Therapy's Most Promising Year
Cell Therapy
- Gene-engineered T cells for cancer therapy
- Pluripotent stem cells progressing to the clinic
- The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?
Cancer Immunotherapy
- Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.
- Cancer Immunotherapy - Review of a Breakout Year and What to Expect for 2017
Vaccines
- Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production
- Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines
Regenerative Medicine
- Pluripotent stem cells in regenerative medicine: challenges and recent progress
- Interspecies organogenesis generates autologous functional islets
- Bioengineering the gut: future prospects of regenerative medicine
Tissue Engineering
- Tissue engineering: Organs from the lab
- Bioinspired seeding of biomaterials using three dimensional microtissues induces chondrogenic stem cell differentiation and cartilage formation under growth factor free conditions
Bioprocessing
- Optimization of Culture Conditions for Expression of Human Interleukin 11
- Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines
© 2018 All Rights Reserved.